GF
TEVA icon

Gerstein Fisher’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Gerstein Fisher’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-4,443
Closed -$256K – 415
2014
Q4 		$256K Buy
+4,443
New +$248K 0.04% 322

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Gerstein Fisher's TEVA Position: Q1 2015 in Review

Gerstein Fisher sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2015, closing a stake of 4,443 shares — an estimated $256K sold.

Gerstein Fisher first reported a position in TEVA in Q4 2014 and held it in 1 quarter. The position peaked at $256K in Q4 2014. 822 funds tracked by Wall St. Rank hold TEVA as of Q1 2015.

  • Gerstein Fisher reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2015 after selling out during the quarter.
  • Gerstein Fisher sold 4,443 Teva Pharmaceutical Industries Limited shares in Q1 2015, an estimated $256K.
  • Gerstein Fisher first reported a position in Teva Pharmaceutical Industries Limited in Q4 2014 and held it in 1 quarter.
  • Gerstein Fisher's Teva Pharmaceutical Industries Limited position peaked at $256K in Q4 2014.
  • 822 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2015.

Based on Gerstein Fisher's 13F filing for Q1 2015, filed 14 May 2015.